Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01237
|
|||||
| Drug Name |
Technetium (99MTC) mebrofenin
|
|||||
| Synonyms |
F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Imaging of liver and gallbladder [ICD11: XD47Y1] | Approved | [1] | |||
| Therapeutic Class |
Diagnostic Radiopharmaceutical Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H19BrN2O5Tc
|
|||||
| Canonical SMILES |
CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C.[Tc]
|
|||||
| InChI |
InChI=1S/C15H19BrN2O5.Tc/c1-8-4-9(2)15(10(3)14(8)16)17-11(19)5-18(6-12(20)21)7-13(22)23;/h4H,5-7H2,1-3H3,(H,17,19)(H,20,21)(H,22,23);/i;1+1
|
|||||
| InChIKey |
JLJSYHOPCNWUNE-IEOVAKBOSA-N
|
|||||
| CAS Number |
CAS 1415247-71-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 486.13 | Topological Polar Surface Area | 107 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| MRP3 | Transporter Info | Multidrug resistance-associated protein 3 | Substrate | [2] | ||
| OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [3] | ||
| OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [4] | ||
| References | ||||||
| 1 | The Drugs.com International Drug Name Database: technetium-tc-99m-mebrofenin | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
| 3 | Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Clin Pharmacol Ther. 2018 Nov;104(5):900-915. | |||||
| 4 | Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol. 2011 Apr;54(4):738-45. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.